BeStock  
Stocks › Biotechnology › APMD

Apnimed APMD

US equityMarket cap rank #3416Biotechnology
$16.09 −$1.16 (-6.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.09 0.00%
Open$17.08
Prev close$17.25
Day range$15.95 – $17.73
Volume248.6K
Market cap$669.84M
P/E (TTM)4.1
Dividend yield–

APMD Stock News

Headlines matching Apnimed or the APMD ticker, most recent first.

  • LifeSci Capital Maintains Apnimed(APMD.US) With Buy Rating, Maintains Target Price $50Market news · 9 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Apnimed(APMD.US), With a Forecast Between $41 to $60Market news · 26 Aug 2026 · Direct mention
  • Evercore Initiates Apnimed(APMD.US) With Buy RatingMarket news · 25 Aug 2026 · Direct mention
  • LifeSci Capital Initiates Apnimed(APMD.US) With Buy Rating, Announces Target Price $50Market news · 25 Aug 2026 · Direct mention
  • BofA Securities Initiates Apnimed(APMD.US) With Buy Rating, Announces Target Price $41Market news · 25 Aug 2026 · Direct mention
  • U.S. Stocks Move | Apnimed (APMD.US), a developer of drugs for sleep apnea, debuts on the U.S. stock market, with shares rising over 11% at the open. PositiveZhitong Finance · 1 Aug 2026 · Direct mention
  • BofA Securities Maintains Apnimed(APMD.US) With Buy Rating, Maintains Target Price $41Market news · 12 Oct 2026 · Direct mention
  • Bank of America Securities Remains a Buy on Apnimed, Inc. (APMD)TipRanks · 12 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on APMD.

Sign in to join the discussion.

Scroll to Top